Capital International Investors Makes New Investment in Billiontoone, Inc. $BLLN

Capital International Investors purchased a new position in Billiontoone, Inc. (NASDAQ:BLLN) in the 4th quarter, HoldingsChannel reports. The fund purchased 178,000 shares of the company’s stock, valued at approximately $14,568,000.

Other institutional investors have also modified their holdings of the company. Nano Cap New Millennium Growth Fund L P acquired a new position in shares of Billiontoone in the fourth quarter worth $82,000. Renaissance Capital LLC acquired a new position in shares of Billiontoone in the fourth quarter worth $201,000. Sigma Planning Corp acquired a new position in shares of Billiontoone in the fourth quarter worth $409,000. Green Alpha Advisors LLC acquired a new position in shares of Billiontoone in the fourth quarter worth $436,000. Finally, FNY Investment Advisers LLC acquired a new position in shares of Billiontoone in the fourth quarter worth $497,000.

Analysts Set New Price Targets

Several research firms have commented on BLLN. Guggenheim boosted their price target on shares of Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. BTIG Research lowered their target price on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. JPMorgan Chase & Co. boosted their target price on shares of Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Wells Fargo & Company lowered their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research note on Thursday, March 5th. Finally, Weiss Ratings downgraded shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $125.29.

Billiontoone Stock Up 8.4%

BLLN stock opened at $102.39 on Wednesday. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18. Billiontoone, Inc. has a twelve month low of $61.96 and a twelve month high of $138.70. The company’s 50 day moving average is $86.68 and its two-hundred day moving average is $88.15. The stock has a market cap of $4.71 billion and a P/E ratio of 186.16.

Billiontoone (NASDAQ:BLLN) last issued its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. The company’s quarterly revenue was up 83.8% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.39) EPS. Research analysts expect that Billiontoone, Inc. will post 0.93 earnings per share for the current fiscal year.

Billiontoone Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.